CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Noncontrolling Interest [Member]	Total
Beginning balance, value at Mar. 31, 2022	$ 1,542	$ 147,460,747	$ (130,329,181)		$ (141,708)	$ 16,991,400
Beginning balance, shares at Mar. 31, 2022	1,541,917
Issuance of common stock for cash under at the market program	$ 58	619,384				619,442
Issuances of common stock for cash under at the market program, shares	57,456
Stock-based compensation expense		215,437				215,437
Net Loss			(2,905,668)		(413)	(2,906,081)
Ending balance, value at Jun. 30, 2022	$ 1,600	148,295,568	(133,234,849)		(142,121)	14,920,198
Ending balance, shares at Jun. 30, 2022	1,599,373
Issuance of common stock for cash under at the market program	$ 691	8,307,078				8,307,769
Issuances of common stock for cash under at the market program, shares	690,628
Issuance of common shares upon vesting of restricted stock units and net stock option exercises	$ 5	(7,978)				(7,973)
Issuance of common shares upon vesting of restricted stock units and net stock option exercises, shares	4,624
Stock-based compensation expense		313,539				313,539
Loss on dissolution of subsidiary					142,121	142,121
Net Loss			(3,807,430)			(3,807,430)
Other Comprehensive Loss
Ending balance, value at Sep. 30, 2022	$ 2,296	156,908,207	(137,042,279)			19,868,224
Ending balance, shares at Sep. 30, 2022	2,294,625
Issuance of common shares upon vesting of restricted stock units and net stock option exercises	$ 2	(1,887)				(1,885)
Issuance of common shares upon vesting of restricted stock units and net stock option exercises, shares	2,312
Stock-based compensation expense		262,613				262,613
Net Loss			(2,849,753)			(2,849,753)
Ending balance, value at Dec. 31, 2022	$ 2,298	157,168,933	(139,892,032)			17,279,199
Ending balance, shares at Dec. 31, 2022	2,296,937
Beginning balance, value at Mar. 31, 2023	$ 2,299	157,426,606	(142,358,555)	(6,141)		15,064,209
Beginning balance, shares at Mar. 31, 2023	2,299,259
Issuance of common stock for cash under at the market program	$ 178	1,085,941				1,086,119
Issuances of common stock for cash under at the market program, shares	177,891
Issuance of common shares upon vesting of restricted stock units and net stock option exercises	$ 7	(8,379)				(8,372)
Issuance of common shares upon vesting of restricted stock units and net stock option exercises, shares	6,397
Stock-based compensation expense		250,114				250,114
Net Loss			(3,282,179)			(3,282,179)
Other Comprehensive Loss				(994)		(994)
Ending balance, value at Jun. 30, 2023	$ 2,484	158,754,282	(145,640,734)	(7,135)		13,108,897
Ending balance, shares at Jun. 30, 2023	2,483,547
Beginning balance, value at Mar. 31, 2023	$ 2,299	157,426,606	(142,358,555)	(6,141)		15,064,209
Beginning balance, shares at Mar. 31, 2023	2,299,259
Ending balance, value at Dec. 31, 2023	$ 2,596	159,751,591	(152,141,311)	(1,619)		7,611,257
Ending balance, shares at Dec. 31, 2023	2,596,538
Beginning balance, value at Jun. 30, 2023	$ 2,484	158,754,282	(145,640,734)	(7,135)		13,108,897
Beginning balance, shares at Jun. 30, 2023	2,483,547
Issuance of common shares upon vesting of restricted stock units and net stock option exercises	$ 9	(9,852)				(9,843)
Issuance of common shares upon vesting of restricted stock units and net stock option exercises, shares	9,329
Stock-based compensation expense		257,181				257,181
Rounding for reverse split
Rounding for reverse split, shares	32
Net Loss			(3,034,456)			(3,034,456)
Other Comprehensive Loss				(2,435)		(2,435)
Ending balance, value at Sep. 30, 2023	$ 2,493	159,001,611	(148,675,190)	(9,570)		10,319,344
Ending balance, shares at Sep. 30, 2023	2,492,908
Issuance of common stock for cash under at the market program	$ 94	186,407				186,501
Issuances of common stock for cash under at the market program, shares	94,304
Issuance of common shares upon vesting of restricted stock units and net stock option exercises	$ 9	(9,382)				(9,373)
Issuance of common shares upon vesting of restricted stock units and net stock option exercises, shares	9,326
Stock-based compensation expense		572,955				572,955
Net Loss			(3,466,121)			(3,466,121)
Other Comprehensive Loss				7,951		7,951
Ending balance, value at Dec. 31, 2023	$ 2,596	$ 159,751,591	$ (152,141,311)	$ (1,619)		$ 7,611,257
Ending balance, shares at Dec. 31, 2023	2,596,538